Reversible posterior leukoencephalopathy syndrome and bevacizumab.
Glusker
Peter
P
Recht
Larry
L
Lane
Barton
B
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D020343:Hypertensive Encephalopathy / Q000139:chemically induced* / Q000473:pathology; D007680:Kidney Neoplasms / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab